{"id":373,"date":"2023-06-07T11:15:57","date_gmt":"2023-06-07T09:15:57","guid":{"rendered":"https:\/\/fastllama.pl\/klient\/ibfm\/?page_id=373"},"modified":"2023-06-07T11:16:56","modified_gmt":"2023-06-07T09:16:56","slug":"ongoing-studies","status":"publish","type":"page","link":"https:\/\/fastllama.pl\/klient\/ibfm\/clinical-trials\/ongoing-studies\/","title":{"rendered":"Ongoing studies"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"373\" class=\"elementor elementor-373\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8f5c419 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8f5c419\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6c4f76c\" data-id=\"6c4f76c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-07911bd elementor-widget elementor-widget-text-editor\" data-id=\"07911bd\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.12.0 - 29-03-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p><strong>Several clinical studies are currently ongoing within the I-BFM SG.<\/strong><\/p><p>Here you find short summaries of a selection of these studies:<\/p><p><strong>ALL<\/strong><\/p><p><a href=\"http:\/\/www.bfm-international.org\/aieop\/aieop_index.html\">AIEOP-BFM ALL 2017 (2017 &#8211; ): Randomized clinical trial for ALL (age 1-18y)<\/a><\/p><p>EsPhALL2017-COGAALL1631: Randomized trial for patients with Ph+ ALLAIEOP-BFM ALL 2017 (2017-2023): Randomized clinical trial (age 1.0-21.9y)<\/p><p>ALLTogether-1 (2021 &#8211; ): Randomized clinical trial for ALL (age up to 45 years)<\/p><p>ALL-IC 2022 (3\/2023 &#8211; ): Randomized clinical trial for ALL in countries with limited resources<\/p><p>Interfant-21 (2\/2023 &#8211; ): Non-randomized clinical trial for all pts under 1y of age with KMT2A rear. ALL<\/p><p>\u00a0<\/p><p><strong>AML <\/strong><\/p><p>&#8211; <a href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2018-002988-25\/DE\">ML-DS 2018<\/a>: for newly diagnosed Down syndrome patients with myeloid leukemia<\/p><p>&#8211; <a href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2017-003422-32\/DE\">AMoRe 2017<\/a>: for molecular relapsed AML patients<\/p><p>&#8211; AIEOP-AML-BFM 2020: frontline protocol (BFM, AIEOP)<\/p><p>&#8211; <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04793919\">ICC APL study 02<\/a>: for newly diagnosed APL patients<\/p><p>&#8211; <a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01828489\">NOPHO-DBH AML 2012<\/a>: frontline protocol (NOPHO DH SHIP)<\/p><p>&#8211; <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02724163\">MyeChild01<\/a>: frontline protocol (SFCE, CCLG, Ireland, Australia, Switzerland)<\/p><p>&#8211; <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04293562\">AAML1831<\/a>: frontline protocol (COG)<\/p><p>&#8211; JPLSG-AML-20: frontline protocol (JCCG)<\/p><p>&#8211; JPLSG-AML-P13: for newly diagnosed APL patients (JCCG)<\/p><p>&#8211; JPLSG-AML-D16: for newly diagnosed Down syndrome patients with myeloid leukemia (JCCG)<\/p><p>&#8211; PedAL trials for relapsed AML patients and early phase trials for relapsed AML (COG)<\/p><p>&#8211; EuPAL trials for relapsed AML patients and early phase trials for relapsed AML (ITCC)<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>CML <\/strong><\/p><p>\u00a0<\/p><p>Bosutinib Study ITCC-054\/AAML1921<br \/>Ponatinib Paediatric INCB84344-102 Study<br \/>Asciminib CABL001I12201 \u2013 ASC4KIDS<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>ELTEC<\/strong><\/p><p><strong>\u00a0<\/strong><\/p><p>Projects in close collaboration with other committees in the field of\u00a0early toxicity:<\/p><ul><li>Supportive care in leukaemia treatment<\/li><li>Toxicity issues in NHL<\/li><li>Middle and late term toxicity in ALL<\/li><li>Prevention, Diagnosis &amp; Management of Thrombosis &amp; Bleeding in Children with Acute Lymphoblastic Leukaemia: European Survey of Current Practice<\/li><\/ul><p>\u00a0<\/p><p>Projects in the field of\u00a0late toxicity\u00a0inside I-BFM :<\/p><ul><li>Survey on your knowledge about your disease and later care<\/li><\/ul><p>\u00a0<\/p><p>Projects in the field of\u00a0late toxicity\u00a0in collaboration with PanCare:<\/p><ul><li>PanCareLife<\/li><li>Survivorship Passport<\/li><\/ul><p><strong>\u00a0<\/strong><\/p><p><strong>\u00a0<\/strong><\/p><p><strong>NHL<\/strong><\/p><p>\u00a0<\/p><p>NHL-BFM and NOPHO trial: B-NHL 2013 study in mature B-cell neoplasms<\/p><p>EICNHL\/i-BFM trial: LBL 2018 study in lymphoblastic lymphoma<\/p><p>EICNHL trial: ALCL-VBL study in SR ALK-pos. ALCL<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>SCT<\/strong><\/p><p>ALL SCT PED 2012 Forum\u00a0(for omitting radiation under majority age). Allogeneic Stem Cell Transplantation in Children and Adolescents with ALL in CR. Prospective controlled randomized international study:<\/p><ul><li>Principal investigator: Christina Peters, E-mail:\u00a0<a href=\"mailto:christina.peters@stanna.at\">peters@stanna.at<\/a><\/li><li>Participating countries: Austria, Argentina, Australia, Chile, Czech Republic. Denmark, Finland, France, Germany, Greece, Hong-Kong, Hungary, Japan, Israel, Italy, The Netherlands, New Zealand, Norway, Polland, Slovakia, Sweden, Spain, Switzerland, Turkey, United Kingdom, USA<\/li><li>The study is open for international recruitment. Randomization is closed.<\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Several clinical studies are currently ongoing within the I-BFM SG. Here you find short summaries of a selection of these studies: ALL AIEOP-BFM ALL 2017 (2017 &#8211; ): Randomized clinical trial for ALL (age 1-18y) EsPhALL2017-COGAALL1631: Randomized trial for patients with Ph+ ALLAIEOP-BFM ALL 2017 (2017-2023): Randomized clinical trial (age 1.0-21.9y) ALLTogether-1 (2021 &#8211; ): [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":50,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-373","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/pages\/373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/comments?post=373"}],"version-history":[{"count":4,"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/pages\/373\/revisions"}],"predecessor-version":[{"id":378,"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/pages\/373\/revisions\/378"}],"up":[{"embeddable":true,"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/pages\/50"}],"wp:attachment":[{"href":"https:\/\/fastllama.pl\/klient\/ibfm\/wp-json\/wp\/v2\/media?parent=373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}